Law Offices of Frank R. Cruz Encourages Aardvark Therapeutics, Inc. (AARD) Shareholders to Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announced a class action lawsuit against Aardvark Therapeutics on behalf of shareholders who purchased stock between February 10, 2025 and May 14, 2026. The complaint alleges securities fraud related to the company's failure to disclose safety issues with ARD-101, which led to a voluntary Phase 3 trial pause and an FDA clinical hold earlier this year.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.